NLRP3 and metabolic dysfunction-associated steatotic liver disease: The transition from NAFLD to NASH is characterized by the activation of inflammatory processes, which may be assessed by measuring inflammatory markers and mediators such as tumor necrosis factor (TNF-α) and the NOD-like receptor-associated protein 3 (NLRP3) inflammasome [14].